Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Galanis

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Bioorganic & Medicinal Chemistry|June 12, 2016
Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivativesSamar Mowafy, A Galanis, Zainab M Doctor, et al.
Health Policy (Amsterdam, Netherlands)|November 17, 2012
Informal payments for maternity health services in public hospitals in GreeceDaphne Ch Kaitelidou, Christina S Tsirona, Petros A Galanis, et al.
Oncology|October 19, 2006
A phase I study of the optimized cryptic peptide TERT(572y) in patients with advanced malignanciesD Mavroudis, I Bolonakis, S Cornet, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Bioorganic & Medicinal Chemistry|June 12, 2016
Toward discovery of mutant EGFR inhibitors; Design, synthesis and in vitro biological evaluation of potent 4-arylamino-6-ureido and thioureido-quinazoline derivativesSamar Mowafy, A Galanis, Zainab M Doctor, et al.
Health Policy (Amsterdam, Netherlands)|November 17, 2012
Informal payments for maternity health services in public hospitals in GreeceDaphne Ch Kaitelidou, Christina S Tsirona, Petros A Galanis, et al.
Oncology|October 19, 2006
A phase I study of the optimized cryptic peptide TERT(572y) in patients with advanced malignanciesD Mavroudis, I Bolonakis, S Cornet, et al.
Pageof 2